UM
Trends of polypharmacy and prescription patterns of antidepressants in Asia
Huang C.-Y.1; Yang S.-Y.1; Mojtabai R.3; Lin S.-K.1; He Y.-L.9; Chong M.-Y.6; Ungvari G.4; Tan C.-H.5; Xiang Y.-T.11; Sartorius N.2; Shinfuku N.10; Chen L.-Y.1
2018-12-01
Source PublicationJournal of Clinical Psychopharmacology
ISSN1533712X 02710749
Volume38Issue:6Pages:598-603
AbstractPurpose Little is known regarding the trend of polypharmacy in Asia. We used data from 5 Asian countries to examine the patterns of antidepressant (AD) prescription and trends of psychotropic polypharmacy over time. Methods We used the cross-sectional, pharmacoepidemiological data from 2004 and 2013 REAP-AD (Research on Asian Psychotropic Prescription Patterns for Antidepressants) to examine the patterns of AD prescriptions in clinical settings in China, Japan, Korea, Singapore, and Taiwan. We compared the trend in polypharmacy (ie, concomitant use of ≥2 classes of psychotropic) among individuals receiving AD prescriptions in 2004 and 2013 using multivariable logistic regression models in different diagnostic categories. Results The proportion of patients with psychotropic polypharmacy decreased from 2004 to 2013 in all 3 diagnostic categories, including mood disorders (adjusted odds ratio [aOR], 0.44 [0.35-0.56]; P < 0.001), anxiety disorders (aOR, 0.58 [0.36-0.94]; P = 0.028), and psychotic disorders (aOR, 0.18 [0.05-0.60]; P = 0.006). Among individuals with AD prescriptions, concomitant use of anxiolytics (including sedative-hypnotics) decreased in patients with mood disorders (aOR, 0.34 [0.27-0.42]; P < 0.001) and anxiety disorders (aOR, 0.43 [0.27-0.67]; P < 0.001). In contrast, concomitant use of antipsychotics in patients with mood disorders increased (aOR, 1.43 [1.15-1.77]; P = 0.001), and concomitant use of mood stabilizers in patients with psychotic disorders also increased (aOR, 3.49 [1.50-8.14]; P = 0.004). Conclusions This is the first study examining trends in psychotropic polypharmacy in East Asia. We found a generally decreasing trend of psychotropic polypharmacy in contrast to the increasing trend reported from Western countries. These findings could offer significant implications for health system reform or policy making.
Keywordantidepressant use polypharmacy prescription pattern
DOI10.1097/JCP.0000000000000954
URLView the original
Language英語
Fulltext Access
Citation statistics
Cited Times [WOS]:1   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionUniversity of Macau
Affiliation1.Taipei City Hospital Taiwan
2.Association for the Improvement of Mental Health Programmes
3.Johns Hopkins Bloomberg School of Public Health
4.University of Western Australia
5.National University of Singapore
6.Chang Gung University
7.Taipei Medical University
8.National Taiwan University
9.Shanghai Mental Health Center
10.Kobe University School of Medicine
11.Universidade de Macau
Recommended Citation
GB/T 7714
Huang C.-Y.,Yang S.-Y.,Mojtabai R.,et al. Trends of polypharmacy and prescription patterns of antidepressants in Asia[J]. Journal of Clinical Psychopharmacology,2018,38(6):598-603.
APA Huang C.-Y..,Yang S.-Y..,Mojtabai R..,Lin S.-K..,He Y.-L..,...&Chen L.-Y..(2018).Trends of polypharmacy and prescription patterns of antidepressants in Asia.Journal of Clinical Psychopharmacology,38(6),598-603.
MLA Huang C.-Y.,et al."Trends of polypharmacy and prescription patterns of antidepressants in Asia".Journal of Clinical Psychopharmacology 38.6(2018):598-603.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Huang C.-Y.]'s Articles
[Yang S.-Y.]'s Articles
[Mojtabai R.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Huang C.-Y.]'s Articles
[Yang S.-Y.]'s Articles
[Mojtabai R.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Huang C.-Y.]'s Articles
[Yang S.-Y.]'s Articles
[Mojtabai R.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.